<DOC>
	<DOC>NCT00199589</DOC>
	<brief_summary>This study evaluates treatment for spastic foot after stroke using ankle foot orthosis with or without selective injection of BTA (Botox).</brief_summary>
	<brief_title>Treatment of Spastic Equinovarus Foot After Stroke</brief_title>
	<detailed_description>This prospective, multicentric open trial evaluates the efficacy of a combined treatment for spastic foot after stroke using ankle foot orthosis with or without selective injection of BTA (Botox) into the tibialis anterior and/or posterior and/or the long toe flexor, and/or medial and lateral gastrocnemius, and/or soleus muscles [300 BTA U per injection (Botox - Allergan), diluted with saline to a concentration of 5U/0,1 mL, with electromyography guided injection]. The patients are followed for one year after treatment.</detailed_description>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Clubfoot</mesh_term>
	<mesh_term>Equinus Deformity</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Stroke patient with equinovarus foot due to severe lower limb extensor spasticity with impaired foot contact during walking Ability to walk for at least 10 meters with or without aid Stroke interval &lt; 12 months Age &gt; 18 years old Weight &gt; 30 kg and &lt; 100 kg Written informed consent Stroke interval &gt; 12 months Age &lt; 18 years old Pregnancy Neuromuscular disease Previous treatment with BTA Fixed contractures impairing mobility MiniMental Status Examination &lt; 25 Aminosides treatment.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Spastic equinovarus</keyword>
	<keyword>Botox</keyword>
	<keyword>Ankle foot orthosis</keyword>
</DOC>